{"entity":{"type":"insider","cik":"0001909680","url":"/insider/0001909680","json_url":"/insider/0001909680.json","name":"Barone Francesca","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":8,"first":"2022-12-12","last":"2026-07-01","span_basis":"filed_date"},"name_variants":[{"name":"Barone Francesca","source":"filing","n_filings":8,"first_seen":"2022-12-12","last_seen":"2026-07-01"}],"transactions":[{"id":6083179,"accession":"0001909680-26-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001909680-26-000002","line_url":"/filing/0001909680-26-000002#line-1","is_derivative":false,"issuer_cik":"0001841387","issuer_name":"Candel Therapeutics, Inc.","issuer_ticker":"CADL","issuer_name_source":null,"issuer_url":"/issuer/0001841387","owner_cik":"0001909680","owner_name":"Barone Francesca","owner_display_name":"Barone Francesca","owner_url":"/insider/0001909680","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23447.0,"shares_display":"23,447","price_per_share":10.0554,"price_display":"10.06","price_state":"stated","total_value":235768.9638,"total_display":"235,768.96","total_whole":"235,769","shares_owned_after":77362.0,"shares_owned_after_display":"77,362","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-29","filed_date":"2026-07-01","scope":"insider"},{"id":4164753,"accession":"0000950170-25-042726","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-042726","line_url":"/filing/0000950170-25-042726#line-2","is_derivative":false,"issuer_cik":"0001841387","issuer_name":"Candel Therapeutics, Inc.","issuer_ticker":"CADL","issuer_name_source":null,"issuer_url":"/issuer/0001841387","owner_cik":"0001909680","owner_name":"Barone Francesca","owner_display_name":"Barone Francesca","owner_url":"/insider/0001909680","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32146.0,"shares_display":"32,146","price_per_share":8.7623,"price_display":"8.76","price_state":"stated","total_value":281672.8958,"total_display":"281,672.90","total_whole":"281,673","shares_owned_after":96527.0,"shares_owned_after_display":"96,527","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-18","filed_date":"2025-03-20","scope":"insider"},{"id":4098859,"accession":"0000950170-25-006726","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-006726","line_url":"/filing/0000950170-25-006726#line-1","is_derivative":false,"issuer_cik":"0001841387","issuer_name":"Candel Therapeutics, Inc.","issuer_ticker":"CADL","issuer_name_source":null,"issuer_url":"/issuer/0001841387","owner_cik":"0001909680","owner_name":"Barone Francesca","owner_display_name":"Barone Francesca","owner_url":"/insider/0001909680","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13534.0,"shares_display":"13,534","price_per_share":7.225,"price_display":"7.22","price_state":"stated","total_value":97783.15,"total_display":"97,783.15","total_whole":"97,783","shares_owned_after":110673.0,"shares_owned_after_display":"110,673","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-15","filed_date":"2025-01-17","scope":"insider"},{"id":4193486,"accession":"0000950170-25-004200","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-004200","line_url":"/filing/0000950170-25-004200#line-1","is_derivative":false,"issuer_cik":"0001841387","issuer_name":"Candel Therapeutics, Inc.","issuer_ticker":"CADL","issuer_name_source":null,"issuer_url":"/issuer/0001841387","owner_cik":"0001909680","owner_name":"Barone Francesca","owner_display_name":"Barone Francesca","owner_url":"/insider/0001909680","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13673.0,"shares_display":"13,673","price_per_share":8.2182,"price_display":"8.22","price_state":"stated","total_value":112367.4486,"total_display":"112,367.45","total_whole":"112,367","shares_owned_after":124207.0,"shares_owned_after_display":"124,207","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-08","filed_date":"2025-01-10","scope":"insider"},{"id":2083484,"accession":"0000950170-24-132925","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-132925","line_url":"/filing/0000950170-24-132925#line-1","is_derivative":false,"issuer_cik":"0001841387","issuer_name":"Candel Therapeutics, Inc.","issuer_ticker":"CADL","issuer_name_source":null,"issuer_url":"/issuer/0001841387","owner_cik":"0001909680","owner_name":"Barone Francesca","owner_display_name":"Barone Francesca","owner_url":"/insider/0001909680","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22081.0,"shares_display":"22,081","price_per_share":4.5556,"price_display":"4.56","price_state":"stated","total_value":100592.2036,"total_display":"100,592.20","total_whole":"100,592","shares_owned_after":137880.0,"shares_owned_after_display":"137,880","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-29","filed_date":"2024-12-03","scope":"insider"},{"id":2117268,"accession":"0000950170-24-084758","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-084758","line_url":"/filing/0000950170-24-084758#line-1","is_derivative":false,"issuer_cik":"0001841387","issuer_name":"Candel Therapeutics, Inc.","issuer_ticker":"CADL","issuer_name_source":null,"issuer_url":"/issuer/0001841387","owner_cik":"0001909680","owner_name":"Barone Francesca","owner_display_name":"Barone Francesca","owner_url":"/insider/0001909680","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14051.0,"shares_display":"14,051","price_per_share":6.4726,"price_display":"6.47","price_state":"stated","total_value":90946.5026,"total_display":"90,946.50","total_whole":"90,947","shares_owned_after":159961.0,"shares_owned_after_display":"159,961","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-17","filed_date":"2024-07-19","scope":"insider"},{"id":2589244,"accession":"0000950170-24-083396","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-083396","line_url":"/filing/0000950170-24-083396#line-1","is_derivative":false,"issuer_cik":"0001841387","issuer_name":"Candel Therapeutics, Inc.","issuer_ticker":"CADL","issuer_name_source":null,"issuer_url":"/issuer/0001841387","owner_cik":"0001909680","owner_name":"Barone Francesca","owner_display_name":"Barone Francesca","owner_url":"/insider/0001909680","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12645.0,"shares_display":"12,645","price_per_share":5.9734,"price_display":"5.97","price_state":"stated","total_value":75533.643,"total_display":"75,533.64","total_whole":"75,534","shares_owned_after":174012.0,"shares_owned_after_display":"174,012","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-11","filed_date":"2024-07-15","scope":"insider"},{"id":6435603,"accession":"0001209191-22-060700","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-060700","line_url":"/filing/0001209191-22-060700#line-1","is_derivative":false,"issuer_cik":"0001841387","issuer_name":"Candel Therapeutics, Inc.","issuer_ticker":"CADL","issuer_name_source":null,"issuer_url":"/issuer/0001841387","owner_cik":"0001909680","owner_name":"Barone Francesca","owner_display_name":"Barone Francesca","owner_url":"/insider/0001909680","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1238.0,"shares_display":"1,238","price_per_share":1.61,"price_display":"1.61","price_state":"stated","total_value":1993.18,"total_display":"1,993.18","total_whole":"1,993","shares_owned_after":2738.0,"shares_owned_after_display":"2,738","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-08","filed_date":"2022-12-12","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":7,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001841387","name":"Candel Therapeutics, Inc.","url":"/issuer/0001841387","role":"Officer (Chief Scientific Officer)","n_filings":8,"first_seen":"2022-12-12","last_seen":"2026-07-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001909680","retrieved_at":"2026-08-24T10:32:54+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}